Share General Information
In its finished dose formulation, Rivaroxaban is an oral anti-clotting substance (anticoagulant drug) which is used in the following instances: to prevent venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), in patients undergoing hip or knee replacement surgery; to prevent stroke and systemic embolism (in patients with atrial fibrillation); to treat DVT and PE and to reduce the risk of recurrent DVT and PE.
About the API
-
Japan DMF
-
Korea DMF
-
US DMF
The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.
For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.
